Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti-depressive drug on the market

Publié le 15 décembre 2021

Baudot J, Soeiro T, Tambon M, Navarro N, Veyrac G, Mezaache S, Micallef J.
Fundam Clin Pharmacol. 2021 Dec 15. doi: 10.1111/fcp.12745. Epub ahead of print. PMID: 34907579.

Retour en haut